Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells
Certain autonomous parvoviruses preferentially replicate in and kill in vitro-transformed cells and may reduce the incidence of spontaneous and implanted tumors in animals. Hence, these viruses and their derivatives are currently under evaluation as antitumor vectors. However, the mechanisms underly...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
27 May 2003
|
| In: |
Cancer gene therapy
Year: 2003, Jahrgang: 10, Heft: 6, Pages: 477-480 |
| ISSN: | 1476-5500 |
| DOI: | 10.1038/sj.cgt.7700591 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.cgt.7700591 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/7700591 
|
| Verfasserangaben: | Markus Moehler, Maja Zeidler, Joerg Schede, Jean Rommelaere, Peter R. Galle, Jan J. Cornelis, and Michael Heike |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1748620401 | ||
| 003 | DE-627 | ||
| 005 | 20230427070947.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210218s2003 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/sj.cgt.7700591 |2 doi | |
| 035 | |a (DE-627)1748620401 | ||
| 035 | |a (DE-599)KXP1748620401 | ||
| 035 | |a (OCoLC)1341393946 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Möhler, Markus |e VerfasserIn |0 (DE-588)112161955X |0 (DE-627)874401909 |0 (DE-576)480916063 |4 aut | |
| 245 | 1 | 0 | |a Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells |c Markus Moehler, Maja Zeidler, Joerg Schede, Jean Rommelaere, Peter R. Galle, Jan J. Cornelis, and Michael Heike |
| 246 | 3 | 0 | |a one |
| 264 | 1 | |c 27 May 2003 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.02.2021 | ||
| 520 | |a Certain autonomous parvoviruses preferentially replicate in and kill in vitro-transformed cells and may reduce the incidence of spontaneous and implanted tumors in animals. Hence, these viruses and their derivatives are currently under evaluation as antitumor vectors. However, the mechanisms underlying their tumor-suppressing properties are not yet understood. We asked whether the lytic parvovirus H1 may enhance the immunogenicity of infected tumor cells. Out of human melanoma and gastrointestinal tumor cells, we selected the cell line SK29-Mel-1 being very susceptible to H1-induced apoptotic killing. Here, no upregulation of HLA class I and costimulatory molecules could be observed following H1 infection. However, a strong release of the immunogenic signal—the inducible heat-shock protein HSP72, but not constitutive HSP73—was observed after H1 infection. The HSP72 release was higher and of longer duration than a conventional heat-shock treatment. We also explored H1 replication and cytotoxicity in human immune cells, as such cells may constitute targets for H1 virus replication. Long-term cultured lymphocytes, monocytes, immature and mature dendritic cells were not susceptible to H1 virus. Altogether, parvovirus-mediated cell killing may in vivo enhance tumor immunogenicity by HSP72 release and thus contribute to the antitumor effect of parvoviruses. | ||
| 700 | 1 | |a Rommelaere, Jean |d 1948- |e VerfasserIn |0 (DE-588)1201673909 |0 (DE-627)1685754767 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer gene therapy |d New York, NY : Nature Publ. Group, 1999 |g 10(2003), 6, Seite 477-480 |h Online-Ressource |w (DE-627)320434702 |w (DE-600)2004200-0 |w (DE-576)115905170 |x 1476-5500 |7 nnas |a Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells |
| 773 | 1 | 8 | |g volume:10 |g year:2003 |g number:6 |g pages:477-480 |g extent:4 |a Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells |
| 856 | 4 | 0 | |u https://doi.org/10.1038/sj.cgt.7700591 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/7700591 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210218 | ||
| 993 | |a Article | ||
| 994 | |a 2003 | ||
| 998 | |g 1201673909 |a Rommelaere, Jean |m 1201673909:Rommelaere, Jean |d 50000 |e 50000PR1201673909 |k 0/50000/ |p 4 | ||
| 999 | |a KXP-PPN1748620401 |e 3858567310 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 18.02.2021"],"recId":"1748620401","language":["eng"],"person":[{"given":"Markus","family":"Möhler","role":"aut","roleDisplay":"VerfasserIn","display":"Möhler, Markus"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Rommelaere, Jean","given":"Jean","family":"Rommelaere"}],"title":[{"title_sort":"Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells","title":"Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells"}],"physDesc":[{"extent":"4 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Nature Publ. Group ; Stockton Press","dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisherPlace":"New York, NY ; New York, NY [u.a.]"}],"id":{"zdb":["2004200-0"],"eki":["320434702"],"issn":["1476-5500"]},"pubHistory":["Nachgewiesen 6.1999 -"],"part":{"issue":"6","pages":"477-480","year":"2003","extent":"4","text":"10(2003), 6, Seite 477-480","volume":"10"},"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 20. November 2018"],"disp":"Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cellsCancer gene therapy","recId":"320434702","language":["eng"],"title":[{"title":"Cancer gene therapy","title_sort":"Cancer gene therapy"}]}],"name":{"displayForm":["Markus Moehler, Maja Zeidler, Joerg Schede, Jean Rommelaere, Peter R. Galle, Jan J. Cornelis, and Michael Heike"]},"origin":[{"dateIssuedDisp":"27 May 2003","dateIssuedKey":"2003"}],"id":{"eki":["1748620401"],"doi":["10.1038/sj.cgt.7700591"]}} | ||
| SRT | |a MOEHLERMARONCOLYTICP2720 | ||